IGIV: Contents, properties, and methods of industrial production - Evolving closer to a more physiologic product

International Immunopharmacology

Volumn 6, Issue 4, 2006, Pages 517-522

  Martin, Turf D ^a  

^a Genesis Marketing Consultants LLC   (United States)

Author keywords

IGIV; Immune globulin; Immunoglobulins

Indexed keywords

ALPHA 1 ANTITRYPSIN; BLOOD CLOTTING FACTOR 8; DIETHYLAMINOETHYL CELLULOSE; GAMUNEX; HUMAN ALBUMIN; HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; OCTANOIC ACID; SEPHADEX; THROMBATE III; UNCLASSIFIED DRUG;

ANION EXCHANGE CHROMATOGRAPHY; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG INDUSTRY; DRUG ISOLATION; DRUG MANUFACTURE; DRUG PURIFICATION; DRUG SAFETY; DRUG TOLERABILITY; DRUG UTILIZATION; FRACTIONATION; HUMAN; INDUSTRIAL PRODUCTION; KIDNEY DISEASE; NONHUMAN; PLASMAPHERESIS; PRIORITY JOURNAL; REVIEW; THROMBOEMBOLISM;

EID: 33644548332     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2005.11.005     Document Type: Article

References (25)

1. G. Virella Immunoglobulin structure G. Virella J.M. Goust H.H. Fudenberg Introduction to medical immunology 1990 Marcel Dekker, Inc. New York, NY 77 89
2. M.G. Colomb, C. Drouet, D.T. Law, and R.H. Painter Structural and biological properties of three intravenous immunoglobulin preparations A. Morell U.E. Nydegger Clinical use of intravenous immunoglobulins 1986 Academic Press London 27 35
3. R. Nezlin General characteristics of immunoglobulin molecules R. Nezlin The immunoglobulins. Structure and function 1988 Academic Press San Diego, CA 4 9
4. F. Skvaril Clinical relevance of IgG subclasses A. Morell U.E. Nydegger Clinical use of intravenous immunoglobulins 1986 Academic Press London 37 45
5. J. Siegel Intravenous immune globulins: therapeutic, pharmaceutical, and cost considerations Pharm Pract News Spec Ed 8 2003 27 31
6. J.A. Hooper, M. Alpern, and S. Mankarious Immunoglobulin manufacturing procedures H.W. Krijnen P.F. Strengers W.G. van Aken Immunoglobulins: proceedings of an international symposium 1988 Central Laboratory of Netherlands Red Cross Blood Transfusion Service Amsterdam 361 380
7. A.W. Burks, H.A. Sampson, and R.H. Buckley Anaphylactic reactions after gammaglobulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA N Engl J Med 314 1986 560 564
8. B. Alving, D.L. Tankersley, B.L. Mason, F. Rossi, D.L. Aronson, and J.S. Finlayson Contact-activated factors: contaminants of immunoglobulin preparations with coagulant and vasoactive activities J Lab Clin Med 96 1980 334 346
9. A.S. Wolberg, R.H. Kon, D.M. Monroe, and M. Hoffman Coagulation factor XI is a contaminant in intravenous immunoglobulin Am J Hematol 65 2000 30 34
10. H.D. Ochs, R.H. Buckley, B. Pirofsky, S.H. Fischer, R.H. Rousell, and C.J. Anderson Safety and patient acceptability of intravenous immune globulin in 10% maltose Lancet 2 1980 1158 1159
11. Gomperts E. Thrombotic events and immune globulin intravenous (IGIV). March 26, 2002. Dear Doctor Letter, Baxter Healthcare Corporation. [5 screens] Available from: http://www.fda.gov/medwatch/SAFETY/2002/baxter_igiv.htm. Access March 16, 2005.
12. B.T. Costa-Carvalho, M. Lin, D. Sole, M.M. Carneiro-Sampaio, R.U. Sorensen, and C.K. Naspitz Metabolic and hematologic changes occurring after rapid infusion of gammaglobulin in patients with antibody deficiency syndromes Sao Paulo Med J 116 1998 1816 1820
13. T. Peters Jr. Historical perspective T. Peters Jr. All about albumin: biochemistry, genetics, and medical applications 1996 Academic Press San Diego, CA 1 8
14. P. Kistler, and H.S. Nitschmann Large scale production of human plasma fractions. Eight years experience with the alcohol fractionation procedure of Nitschmann, Kistler and Lergier Vox Sang 7 1962 414 424
15. M.H. Stryker, M.J. Bertolini, and Y. Hai Blood fractionation: proteins, advances in biotechnological processes 1985 Alan R. Liss, Inc. New York, NY 276 336
16. J.L. Fahey, and A.P. Horbett Human gamma globulin fractionation on anion exchange cellulose columns J Biol Chem 234 1959 2645 2651
17. H.H. Hoppe, T. Mester, W. Hennig, and H.J. Krebs Prevention of Rh-immunization. Modified production of IgG anti-Rh for intravenous application by ion-exchange chromatography (IEC) Vox Sang 25 1973 308 316
18. A.D. Friesen, J.M. Bowman, and W.C. Bees Column ion exchange chromatographic production of human immune serum globulin for intravenous use Vox Sang 48 1985 201 212
19. W. Lebing, K. Remington, C. Schreiner, and H.I. Paul Properties of a new intravenous immunoglobulin (IGIV-C, 10%) produced by caprylate virus inactivation and column chromatography Vox Sang 84 2003 193 201
20. J.L. Lundblad, and R. Seng Inactivation of lipid-enveloped viruses in proteins with caprylate Vox Sang 60 1991 75 81
21. W. Stephan Undegraded human immunoglobulin for intravenous use Vox Sang 28 1975 422 437
22. Y. Masuho, K. Tomibe, K. Matsuzawa, and A. Ohtsu Development of an intravenous gamma-globulin with Fc activities: I. Preparation and characterization of S-sulfonated human gamma-globulin Vox Sang 32 1977 175 181
23. S. Barandun, A. Morell, and F. Skvaril Clinical experience with immunoglobulin for intravenous use B.M. Alving J.S. Finlayson Immunoglobulins: characteristics and uses of intravenous preparations 1980 US Government Printing Office Washington, DC 31 35
24. F. Skvaril, and S. Barandun In vitro characterization of immunoglobulins for intravenous use B.M. Alving J.S. Finlayson Immunoglobulins: characteristics and uses of intravenous preparations 1980 US Government Printing Office Washington, DC 201 206
25. D.D. Schroeder, D.L. Tankersley, and J.L. Lundblad A new preparation of modified immune serum globulin (human) suitable for intravenous administration: II. Functional characterization Vox Sang 40 1981 383 394